Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Pharmacological Reports : PR|March 25, 2009
Molecular determinants of heart failure with normal left ventricular ejection fractionAttila Borbély, Zoltán Papp, István Edes, et al.
Current Pharmaceutical Biotechnology|January 28, 2012
How cardiomyocytes make the heart oldZoltán Papp, Dániel Czuriga, László Balogh, et al.
Orvosi Hetilap|December 19, 2012
[Heart failure with preserved ejection fraction (diastolic heart failure)]István Czuriga, Attila Borbély, Dániel Czuriga, et al.
Current Pharmaceutical Biotechnology|January 28, 2012
Cellular mechanisms for diastolic dysfunction in the human heartDániel Czuriga, Walter J Paulus, István Czuriga, et al.
Journal of Cellular and Molecular Medicine|August 2, 2008
The peroxynitrite evoked contractile depression can be partially reversed by antioxidants in human cardiomyocytesZita Hertelendi, Attila Tóth, Attila Borbély, et al.
ESC Heart Failure|August 24, 2017
Altered myocardial force generation in end-stage human heart failureZoltán Papp, Jolanda van der Velden, Attila Borbély, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2006
Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibitionPetri Kaheinen, Piero Pollesello, Zita Hertelendi, et al.
Journal of Cardiovascular Pharmacology|August 24, 2005
Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximoneSzabolcs Szilágyi, Piero Pollesello, Jouko Levijoki, et al.
Pageof 5